Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study
Franzosi, M.G.
Italian Heart Journal. Suppl Official Journal of the Italian Federation of Cardiology 2(9): 1034-1036
2001
ISSN/ISBN: 1129-4728 PMID: 11675828 Document Number: 535470
Document emailed within 1 workday
Related Documents
Gillmann, H.; Colberg, K.; Keller, H.P.; Orth, H.F.; Börner, W.; Fritze, E.; Gebauer, D.; Grosser, K.D.; Heckner, F.; Körtge, P.; van de Loo, J.; Pezold, F.A.; Poliwoda, H.; Praetorius, F.; Schmutzler, R.; Schneider, B.; Zekorn, D. 1973: Fibrinolytic therapy of acute myocardial infarct. II. German-Swiss common study. 2. Results of electrocardiographic studies Zeitschrift für Kardiologie 62(3): 193-214Bordalo-Sá, A.L.; Ferreira, D.; Tuna, J.L.; Longo, A.; Correia, M.J.; Diogo, A.N.; Gaspar, F.; Ribeiro, C.; Soares-Costa, J.T. 1999: The variability of the heart rate in the first 24 hours after fibrinolytic therapy in acute myocardial infarct Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 18(3): 261-265
Ottani, F.; Bresciani, B.; La Vecchia, L.; Favero, L.; Fontanelli, A.; Galvani, M. 2002: Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 3(5): 544-554
Dudek, D.; Bartuś, Sław.; Zmudka, K.; Kuta, M.; Legutko, J.; Wizimirski, M.; Pieniazek, P.; Przewłocki, T.; Gajos, G.; Bryniarski, L.; Dragan, J.; Pasowicz, Mław.; Zorkun, C.; Dubiel, J.S. 2002: Assessment of myocardial reperfusion in patients with acute myocardial infarction treated with combination of fibrinolysis and IIb/IIIa platelet inhibitor Przeglad Lekarski 59(1): 1-6
Pinelli, G.; Urbinati, S. 2001: Bolus fibrinolytic therapy in acute myocardial infarction Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 2(12): 1360-1362
Davies, C.; Christenson, J.; Campbell, A.; Cox, J.L.; Huynh, T.; Matheson, S.; Daly, P.A.; Hilbe, J. 2004: Fibrinolytic therapy in acute myocardial infarction: time to treatment in Canada Canadian Journal of Cardiology 20(8): 801-805
Moliterno, D.J.; Topol, E.J. 1997: Conjunctive use of platelet glycoprotein IIb/IIIa antagonists and thrombolytic therapy for acute myocardial infarction Thrombosis and Haemostasis 78(1): 214-219
Andreotti, F.; Biondi-Zoccai, G.G.L. 2002: Potentiation of fibrinolytic therapy in acute myocardial infarction: expanding the role of ACE-inhibitors Thrombosis and Haemostasis 88(2): 176-178
Fischer, E.J.; Nell, J.; Ahmed, M.; Schmalz, W. 1979: Early fibrinolytic treatment of acute myocardial infarct Die Medizinische Welt 30(42): 1567-1574
Fornaro, G.; Lazzero, M.; Giacalone, A.; Aralda, D.; Prando, M.Domenica.; Rossi, L.; Bongo, A.Sante. 2008: Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A post-mortem study to verify cardiac rupture as a cause of death Giornale Italiano di Cardiologia 9(6): 408-420
Gritsiuk, A.I.; Angelutsa, P.A. 1987: Clotting and fibrinolytic activity of erythrocytes during different courses of the acute period of a myocardial infarct Kardiologiia 27(2): 89-91
Shevchuk, M.I. 1987: Blood clotting and fibrinolytic indices in a functional test of acute myocardial infarct patients Vrachebnoe Delo 5: 60-63
Nishida, M.; Matsuno, H.; Kozawa, O.; Ueshima, S.; Matsuo, O.; Collen, D.; Uematsu, T. 2000: tPA, but not uPA, significantly affects antithrombotic therapy by a glycoprotein IIb/IIIa antagonist, but not by a factor Xa inhibitor Journal of Cardiovascular Pharmacology 36(6): 770-775
Sochman, J. 1994: When to begin reperfusion therapy in patients with acute myocardial infarct: in the early phase or whenever? Vnitrni Lekarstvi 40(7): 460-464
Maugeri Saccà, C.; Arrigo, F.; Costa, G.; Cavalli, A.; Giannetto, M.; Virga, T.; Cento, D.; La Presa, V. 1992: The frequency of early coronary reperfusion assessed by electrocardiographic criteria in relation to the timing of thrombolytic therapy in acute myocardial infarct Minerva Cardioangiologica 40(3): 65-69
Ogunyankin, K. 1994: Thrombolytic therapy for acute myocardial infarction: GUSTO criticized New England Journal of Medicine 330(7): 505; Author Reply 506
Verheugt, F.W.; Lamfers, E.J.; Aengevaeren, W.R. 2003: Reperfusion therapy for patients with an acute myocardial infarct with ST-segment elevation: fibrinolysis versus transport to a cardiac center for primary angioplasty Nederlands Tijdschrift Voor Geneeskunde 147(41): 2001-2004
Ferreira, D. 2003: Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 22(7-8): 1005-1009
Caputo, R.P.; Giambartolomei, A.; Simons, A.; Reger, M.; Wagner, S.; Esente, P. 2001: Adjunctive therapies in the cath lab. use of combination glycoprotein IIb/IIIa inhibitor and direct thrombin inhibitor drugs to support percutaneous coronary stent placement in a patient with renal insufficiency and heparin-induced thrombocytopenia Journal of Invasive Cardiology 13(9): 657-660
Haapanen, A.; Leinonen, A.; Seppänen, S. 1984: Preangioplasty fibrinolytic therapy using SP-54 including acute and subacute occlusions Annales de Radiologie 27(4): 340